Compression therapy with compression stockings,
does it really help with Prevention of recurrent leg cellulitis in chronic edema?
research showsGrade C. Recurrence was 6/41 (15%) versus 17/43 (40%), an absolute reduction of 25 points; HR 0.23 (95% CI 0.09 to 0.59). The 84-person trial stopped early after an interim analysis.
ads claimStockings are widely sold in Korea, but pressure selection and arterial status require review.
Useful facts when choosing a product
- Widely sold in Korea.
- Single-center specialist lymphedema setting.
- Fit and arterial circulation matter.
What the research actually shows
Four gates: ① Defects: early stopping and small size. ② Listed items: early stopping and total enrollment below 200. ③ The paper reports a planned interim analysis but "post hoc stopping rules" and 84 randomized participants. ④ A larger trial and prespecified boundary were feasible. Open-label ascertainment was not added as a defect under the recorded-outcome and treatment-decision test.
Why this is classified as C (56)
Publicly funded hard-outcome evidence with a large effect, but two listed defects give C, 56.
Counterpoint. Small trials stopped early can overestimate effects.
Rejudgment record. Axes and scorer agree — Absolute recurrence difference, early stopping, and sample size
| Endpoint | H | Hard endpoint - actual events such as death |
| Replication | R1 | Single confirmatory trial |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | E+ | Meets the clinically important threshold |
The scoring table and the verdict agree (C).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Prevention of recurrent cellulitis | C | Absolute recurrence fell by 25 points. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Single-center open-label randomized trial | 43 | Calvary Public Hospital Bruce funded clinician time to initiate and manage the trial | Recurrence of cellulitis | 6/41 (15%) vs 17/43 (40%); absolute difference -25 points; HR 0.23 (95% CI 0.09 to 0.59) | Pivotal publicly funded clinical-event evidence |
Receipt — 1 References
All 1 cited sources were verified for existence at the original page (as of 2026-08-26).
Final verification and publication gate: Codex · Verification cutoff: 2026-08-26 · Corrections: none
Cite this verdict
[Chamgap] Benefit of Compression Stockings for Preventing Recurrent Cellulitis of the Leg in Chronic Edema — Evidence Grade C·56. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/immunity/compression-stockings-chronic-edema-recurrent-cellulitis/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.